Table 4:
Currently available Point-of-Care Tests for Cells and Exosomes in Urine
| Analyte (ref) | Type of test (r/c) | Detection Method | Site of Use | Indications | Time | LoD / working range | Advantages | Disadvantages |
|---|---|---|---|---|---|---|---|---|
| Erythrocytes (113) | LFA— UBC rapid (c) | Colorimetric | Laborotory Clinic office |
Macrohematuria | 10 min | NA | Rapid; Quantitative; Easy operation | POC reader concile ® Ω100 required for quantitative analysis |
| LFA— NMP22 BladderChek (c) |
30 min | NA | Rapid; Quantitative; Easy operation | POC reader concile ® Ω100 required for quantitative analysis | ||||
| LFA— BTA stat (c) | 5 min | NA | Rapid; Easy operation | Qualitative | ||||
| Exosomes (114) | Microchip ELISA (r) | Colorimetric | Laborotory Clinic office |
Bladder cancer | 2.5 hours | Exosome size range of 30 to 200 nm | Quantitative; High TPR & TNR, Smartphone used for imaging |
Laptop required for quantitative analysis |
Abbreviations: (c): Available for commercial use; LFA: Lateral flow assay; LoD: Limit of detection; (r): Available for research use; TNR: True negative rate; TPR: True positive rate